全文获取类型
收费全文 | 104725篇 |
免费 | 9861篇 |
国内免费 | 6723篇 |
专业分类
耳鼻咽喉 | 1050篇 |
儿科学 | 1209篇 |
妇产科学 | 1390篇 |
基础医学 | 12958篇 |
口腔科学 | 1937篇 |
临床医学 | 13475篇 |
内科学 | 15392篇 |
皮肤病学 | 1493篇 |
神经病学 | 5846篇 |
特种医学 | 4222篇 |
外国民族医学 | 58篇 |
外科学 | 11861篇 |
综合类 | 14862篇 |
现状与发展 | 25篇 |
一般理论 | 25篇 |
预防医学 | 6742篇 |
眼科学 | 3406篇 |
药学 | 10550篇 |
97篇 | |
中国医学 | 5350篇 |
肿瘤学 | 9361篇 |
出版年
2024年 | 279篇 |
2023年 | 1448篇 |
2022年 | 3498篇 |
2021年 | 5304篇 |
2020年 | 4015篇 |
2019年 | 3653篇 |
2018年 | 3874篇 |
2017年 | 3336篇 |
2016年 | 3436篇 |
2015年 | 4920篇 |
2014年 | 6051篇 |
2013年 | 5694篇 |
2012年 | 8287篇 |
2011年 | 8737篇 |
2010年 | 5601篇 |
2009年 | 4380篇 |
2008年 | 5735篇 |
2007年 | 5565篇 |
2006年 | 5552篇 |
2005年 | 5196篇 |
2004年 | 3656篇 |
2003年 | 3420篇 |
2002年 | 2757篇 |
2001年 | 2232篇 |
2000年 | 2071篇 |
1999年 | 2244篇 |
1998年 | 1415篇 |
1997年 | 1366篇 |
1996年 | 1044篇 |
1995年 | 978篇 |
1994年 | 839篇 |
1993年 | 522篇 |
1992年 | 654篇 |
1991年 | 540篇 |
1990年 | 506篇 |
1989年 | 443篇 |
1988年 | 398篇 |
1987年 | 325篇 |
1986年 | 289篇 |
1985年 | 246篇 |
1984年 | 155篇 |
1983年 | 108篇 |
1982年 | 64篇 |
1981年 | 69篇 |
1980年 | 47篇 |
1979年 | 84篇 |
1978年 | 32篇 |
1974年 | 31篇 |
1973年 | 23篇 |
1968年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
31.
32.
我国奶牛养殖规模不断扩大,奶业产值比重逐步提高,给奶牛疫病防治带来巨大压力。奶牛乳房炎及细菌性肺炎等呼吸系统疾病和细菌性肠炎等消化系统疾病最为常见,抗菌药物的使用成为主要防治手段。但抗菌药物的不当使用易使细菌产生耐药性,增加临床治疗的成本和难度,危害我国奶牛产业发展。本文对截至2021年7月我国和美国、英国、日本、欧盟批准用于奶牛的抗菌药物产品进行整理、统计与分析,包括抗菌药物的分类、剂型以及适应证等,旨在为我国奶牛用抗菌药物管理、合理用药和新兽药开发提供参考。 相似文献
33.
34.
35.
PurposeType B aortic dissection is a rare but life-threatening disease. Thoracic endovascular aortic repair (TEVAR) was widely used for Type B aortic dissection patients in the last decade due to the lower mortality and morbidity compared with open chest surgical repair (OCSR). AKI in type B aortic dissection is a well-recognized complication and indicates poor short-term and long-term outcome. The objective of this concise review was to identify the risk factors and the impact of AKI on type B aortic dissection patients.Methods and resultsA literature search was performed using PubMed, Embase, MEDLINE, and Cochrane Library with the search terms ‘type B aortic dissection’ and ‘acute kidney injury’ (AKI), and all English-language literatures published in print or available online from inception through August 2020 were thoroughly reviewed. Studies that reported relative AKI risks and outcomes in type B aortic dissection patient were included. Major mechanisms of AKI in type B aortic dissection included renal hypoperfusion, inflammation response, and the use of contrast medium. Type B aortic dissection patients with AKI significantly had increased hospital stay duration, need of renal replacement therapy, and 30-d and 1-year mortality.ConclusionsAKI in type B aortic dissection is a well-recognized complication and associated with poor short-term and long-term outcome. Early identification of high-risk patients, early diagnosis of AKI, stabilization of the hemodynamic parameters, avoidance of nephrotoxic drugs, and optimization of the use of contrast agents are the major strategies for the reduction of AKI in type B aortic dissection patients. 相似文献
36.
本研究拟探讨染料木黄酮对前列腺癌细胞LNCaP和CWR22RV1的增殖、迁移和侵袭能力的影响。一、材料与方法1.材料:前列腺癌细胞株LNCaP和CWR22RV1(中国科学院上海生命科学研究院);Genistein(天津科瑞泰科技有限公司);RPMI 1640、胎牛血清(FBS)、胰蛋白酶(美国Gibco公司);E-钙黏蛋白(E-cadherin)、N-钙黏蛋白(N-cadherin)、波形蛋白(Vimentin,Abcam公司);聚氰基丙烯酸正丁酯(BCA)试剂盒、十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)上样缓冲液(×5)及蛋白质印迹法(Western blot)试剂盒(上海市碧云天生物公司);2.实验方法:采用噻唑蓝(MTT)实验、划痕实验和Transwell实验检测Genistein对细胞增殖、迁移及侵袭能力的影响。采用Western blot检测E-cadherin、N-cadherin、Vimentin、CD44和Oct-4的表达水平。 相似文献
37.
38.
Toshiro Hara Rony Chanoch-Myers Nathan D. Mathewson Chad Myskiw Lyla Atta Lillian Bussema Stephen W. Eichhorn Alissa C. Greenwald Gabriela S. Kinker Christopher Rodman L. Nicolas Gonzalez Castro Hiroaki Wakimoto Orit Rozenblatt-Rosen Xiaowei Zhuang Jean Fan Tony Hunter Inder M. Verma Kai W. Wucherpfennig Itay Tirosh 《Cancer cell》2021,39(6):779-792.e11
39.
Xue Yao Yan Zhang Jian Hao Hui-Quan Duan Chen-Xi Zhao Chao Sun Bo Li Bao-You Fan Xu Wang Wen-Xiang Li Xuan-Hao Fu Yong Hu Chang Liu Xiao-Hong Kong Shi-Qing Feng 《中国神经再生研究》2019,(3)
Ferroptosis is an iron-dependent novel cell death pathway. Deferoxamine, a ferroptosis inhibitor, has been reported to promote spinal cord injury repair. It has yet to be clarified whether ferroptosis inhibition represents the mechanism of action of Deferoxamine on spinal cord injury recovery. A rat model of Deferoxamine at thoracic 10 segment was established using a modified Allen's method. Ninety 8-week-old female Wistar rats were used. Rats in the Deferoxamine group were intraperitoneally injected with 100 mg/kg Deferoxamine 30 minutes before injury. Simultaneously, the Sham and Deferoxamine groups served as controls. Drug administration was conducted for 7 consecutive days. The results were as follows:(1) Electron microscopy revealed shrunken mitochondria in the spinal cord injury group.(2) The Basso, Beattie and Bresnahan locomotor rating score showed that recovery of the hindlimb was remarkably better in the Deferoxamine group than in the spinal cord injury group.(3) The iron concentration was lower in the Deferoxamine group than in the spinal cord injury group after injury.(4) Western blot assay revealed that, compared with the spinal cord injury group, GPX4, xCT, and glutathione expression was markedly increased in the Deferoxamine group.(5) Real-time polymerase chain reaction revealed that, compared with the Deferoxamine group, mRNA levels of ferroptosis-related genes Acyl-CoA synthetase family member 2(ACSF2) and iron-responsive element-binding protein 2(IREB2) were up-regulated in the Deferoxamine group.(6) Deferoxamine increased survival of neurons and inhibited gliosis. These findings confirm that Deferoxamine can repair spinal cord injury by inhibiting ferroptosis. Targeting ferroptosis is therefore a promising therapeutic approach for spinal cord injury. 相似文献
40.